LIMINAL BIOSCIENCES INC. WAIVER AND AMENDMENT OF REGISTRATION RIGHTSWaiver and Amendment of Registration Rights • March 20th, 2020 • Liminal BioSciences Inc. • Pharmaceutical preparations
This waiver and amendment (this “Waiver and Amendment”) is entered into as of March 17, 2020, by and among Liminal BioSciences Inc. (formerly known as Prometic Life Sciences Inc.), a Canadian corporation (the “Company”) and Consonance Capital Master Account L.P. and P Consonance Opportunities Ltd. (each an “Investor” and, together, the “Investors”). This Waiver and Amendment is being delivered pursuant to Section 3.8 and Section 3.9 of that certain registration rights agreement (the “Registration Rights Agreement”), dated April 23, 2019, by and among the Company and the Investors. Capitalized terms used but not defined herein shall have the respective meanings set forth in the Registration Rights Agreement.
